Evidence map›Paper›PMID 31440957›Full record

ArticleJournal of assisted reproduction and genetics2019

ICSI does not offer any benefit over conventional IVF across different ovarian response categories in non-male factor infertility: a European multicenter analysis.

Panagiotis Drakopoulos, Juan Garcia-Velasco, Ernesto Bosch, Christophe Blockeel, Michel de Vos, Samuel Santos-Ribeiro, Antonis Makrigiannakis, Herman Tournaye, Nikolaos P Polyzos

Erratum issuedAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Indications for Micro-Injection of Sperm in Assisted Reproduction: A Consensus Statement.The Australian & New Zealand journal of obstetrics & gynaecology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. ICSI for non-male factor: do we practice what we preach?Journal of assisted reproduction and genetics · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Panagiotis DrakopoulosCenter for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium. panagiotisdrakopoulos@hotmail.com.ORCID http://orcid.org/0000-0002-9262-785X
Juan Garcia-VelascoInstituto Valenciano de Infertilidad, IVI-RMA Madrid, Madrid, Spain.
Ernesto BoschInstituto Valenciano de Infertilidad, IVI-RMA Valencia, Valencia, Spain.
Christophe BlockeelCenter for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
Michel de VosCenter for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
Samuel Santos-RibeiroIVI-RMA Lisbon, Lisbon, Portugal.
Antonis MakrigiannakisDepartment of Obstetrics and Gynecology, Medical School, University of Crete, 71110, Heraklion, Crete, Greece.
Herman TournayeCenter for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
Nikolaos P PolyzosFaculty of Medicine and Pharmacy, Department of Surgical and Clinical Science, Vrije Universiteit Brussel, Brussels, Belgium.
Vrije Universiteit Brussel · BEUniversidad Rey Juan Carlos · ESUniversity of Crete · GRUniversity of Lisbon · PTValencian Infertility Institute · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate whether ICSI offers any benefit compared with IVF in different ovarian response categories in case of non-male factor infertility.

methodsThis is a retrospective multicenter analysis using individual patient data, conducted in 15 tertiary referral hospitals in Europe (1 center in Belgium and 14 in Spain). The study included the first cycle of all patients undergoing ovarian stimulation for IVF or ICSI in a GnRH antagonist protocol. Only patients having either IVF or ICSI for non-male factor infertility were included. Patients were divided into 4 groups based on their ovarian response as follows: group A, poor responders (1-3 oocytes); group B, suboptimal responders (4-9 oocytes); group C, normal responders (10-15 oocytes); group D, high responders (> 15 oocytes).

resultsIn total, 4891 patients were analyzed, of whom 4227 underwent ICSI and 664 IVF. There was no significant difference for the insemination method (ICSI vs. IVF) used among the different ovarian response categories: 87% vs. 13%, 87% vs. 13%, 86% vs. 14%, 84% vs. 16%, for groups A, B, C, and D, respectively, p value = 0.35. Mean fertilization rates and embryo utilization rates were comparable between IVF and ICSI in the whole cohort. Fresh and cumulative LBR did not differ significantly for IVF and ICSI in poor, suboptimal, normal, and high responders.

conclusionThere is no advantage of ICSI over IVF as insemination method for non-male factor infertility, irrespective of the ovarian response. The number of oocytes retrieved has no value for the selection of the insemination procedure in case of non-male infertility.

Indexed as

AdultBirth RateEuropeFemaleFertilization in VitroHumansInfertilityMaleOocyte RetrievalOocytesOvaryOvulation InductionPregnancyPregnancy RateSpainSperm Injections, IntracytoplasmicFertilization ratesICSIIVFOocytesOvarian response

Identifiers

PMID31440957
PMCPMC6823343
OpenAlexW2969854077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.